JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

A4127 GSK1070916

Target: Aurora Kinases

Summary: Aurora B/C inhibitor

≥25.4 mg/mL
A5703 BMS-777607

Target: MET

Summary: C-Met inhibitor, potent and selective

≥25.65 mg/mL
A8169 Everolimus (RAD001)

8 Citation

Target: mTOR

Summary: MTOR inhibitor

≥47.91 mg/mL
A3133 A 83-01

Summary: ALK-5 inhibitor

≥21.1 mg/mL
A1971 Etoposide

4 Citation

Target: Topoisomerases

Summary: Topo II inhibitor

≥29.45 mg/mL
A3020 (R)-Crizotinib

2 Citation

Target: c-MET

Summary: C-MET/ALK inhibitor,potent and ATP-competitve

insoluble in H2O; insoluble in EtOH; ≥7.51 mg/mL
B2266 LDE225 (NVP-LDE225,Erismodegib)

1 Citation

Target: Smoothened

Summary: Smoothened inhibitor,potent and selective

≥24.3 mg/mL
A3632 Motesanib

Target: VEGFR

Summary: Inhibitor of Flk-1/Flt-4/PDGFR-/c-Kit

≥42 mg/mL
A8214 AZD8055

2 Citation

Target: mTOR

Summary: MTOR inhibitor

≥23.3 mg/mL
A4453 NSC 687852 (b-AP15)

Target: Deubiquitinating enzymes (DUBs)

Summary: 19S regulatory particle Inhibitor

insoluble in EtOH; insoluble in H2O; ≥20.95 mg/mL